Literature DB >> 18513853

Disorganisation of cytoskeleton in cells resistant to photodynamic treatment with decreased metastatic phenotype.

Adriana Casas1, Francisco Sanz-Rodriguez, Gabriela Di Venosa, Lorena Rodriguez, Leandro Mamone, Alfonso Blázquez, Pedro Jaén, Alcira Batlle, Juan C Stockert, Angeles Juarranz.   

Abstract

The appearance of cells resistant to photodynamic therapy (PDT) is crucial for the outcome of this antitumoral treatment. We had previously isolated two sublines resistant to PDT derived from the mammary adenocarcinoma LM3 [A. Casas, C. Perotti, B. Ortel, G. Di Venosa, M. Saccoliti, A. Batlle, T. Hasan, Induction of murine tumour cell lines resistant to ALA-mediated Photodynamic Therapy, Int. J. Oncol. 29 (2006) 397-405.]. These clones have severely impaired its metastatic potential in vivo together with decreased general anchorage-dependent adhesion and invasion. In the present work we analyzed the differential expression and distribution of cytoskeleton and adhesion proteins in these cell lines. In both resistant clones, loss of actin stress fibers and disorganization of the actin cortical rim was observed. E-cadherin and beta-catenin and vinculin distribution was also disorganized. However, Western blot assays did not show differential expression of actin, E-cadherin, vinculin or beta-catenin. It was demonstrated that PDT strongly affects cell-cell and cell-substrate adhesion through the reorganization of some cytoskeletal and adhesion proteins. Changes in the metastasis phenotypes previously found are likely to be ascribed to these differences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513853     DOI: 10.1016/j.canlet.2008.04.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

3.  Plasma-derived Exosomes Reverse Epithelial-to-Mesenchymal Transition after Photodynamic Therapy of Patients with Head and Neck Cancer.

Authors:  Marie-Nicole Theodoraki; Saigopalakrishna S Yerneni; Cornelia Brunner; Joannis Theodorakis; Thomas K Hoffmann; Theresa L Whiteside
Journal:  Oncoscience       Date:  2018-04-29

4.  Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.

Authors:  Silvia Rocio Lucena; Alicia Zamarrón; Elisa Carrasco; Miguel Angel Marigil; Marta Mascaraque; Montserrat Fernández-Guarino; Yolanda Gilaberte; Salvador González; Angeles Juarranz
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

5.  Disaccharides obtained from carrageenans as potential antitumor agents.

Authors:  Gustavo H Calvo; Vanina A Cosenza; Daniel A Sáenz; Diego A Navarro; Carlos A Stortz; Mariela A Céspedes; Leandro A Mamone; Adriana G Casas; Gabriela M Di Venosa
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

6.  Evaluation of photodynamic therapy in adhesion protein expression.

Authors:  Cristina Pacheco-Soares; Maira Maftou-Costa; Carolina Genúncio DA Cunha Menezes Costa; Andreza Cristina DE Siqueira Silva; Karen C M Moraes
Journal:  Oncol Lett       Date:  2014-05-16       Impact factor: 2.967

7.  Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).

Authors:  Mamoru Tanaka; Hiromi Kataoka; Shigenobu Yano; Takuya Sawada; Haruo Akashi; Masahiro Inoue; Shugo Suzuki; Yusuke Inagaki; Noriyuki Hayashi; Hirotada Nishie; Takaya Shimura; Tsutomu Mizoshita; Yoshinori Mori; Eiji Kubota; Satoshi Tanida; Satoru Takahashi; Takashi Joh
Journal:  Oncotarget       Date:  2016-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.